Tirzepatide 20mg

Tirzepatide 20mg is a synthetic peptide used in laboratory research investigating metabolic signaling, incretin receptor activity, glucose-related pathways, energy regulation, and cellular responses associated with GIP and GLP-1 receptor activation.

Tirzepatide is characterized as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Because it interacts with two major incretin-related receptor systems, it has become an important compound in metabolic and biochemical research.

Research involving tirzepatide may examine areas such as:

• GIP receptor signaling
• GLP-1 receptor signaling
• Incretin pathway interactions
• Cellular metabolic signaling
• Glucose-regulation mechanisms
• Energy homeostasis pathways
• Receptor activation and downstream signaling
• Metabolic peptide research

The 20mg format provides researchers with a clearly identified material suitable for controlled experimental protocols and laboratory investigations.

Peptides R US supplies research materials in Canada with an emphasis on product identification, consistency, and research-focused presentation.

Product Details

• Compound: Tirzepatide
• Strength: 20mg
• Research Area: Metabolic and incretin receptor research
• Primary Pathways: GIP and GLP-1 receptor signaling
• Intended Use: Laboratory and scientific research only
• Region: Canada

Research Use Only: This product is intended strictly for laboratory, analytical, and scientific research. It is not intended for human consumption, medical treatment, diagnostic use, or veterinary use.